Challenges and opportunities for cancer stem cell‐targeted immunotherapies include immune checkpoint inhibitor, cancer stem cell‐dendritic cell vaccine, chimeric antigen receptor immune cells, and modified exosomes
Year: 2024
Type: review
DOI: 10.1002/jbt.23719
Authors: Abdullah Alqarni, Saade Abdalkareem Jasim, Farag M. A. Altalbawy, Harpreet Kaur, Irwanjot Kaur, Carlos Rodriguez‐Benites, Mahamedha Deorari, Enas R. Alwaily, Ahmed M. Al‐Ani, Ahmed H. Redhee
Institutions: King Khalid University, University of Al Maarif, University of Tabuk, Shobhit University, Arka Jain University, Jain University, Vivekananda Global University, National University of Trujillo, Uttaranchal University, Thi Qar University, Al-Ayen Iraqi University, Al-Nisour University, University of Babylon, Iraqi University, Islamic University of Najaf, Islamic University Babylon Campus
Language: English
Topic: Cancer Cells and Metastasis
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4398137239